Wim Waelput
Overview
Explore the profile of Wim Waelput including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
715
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lauwers Y, De Groof T, Vincke C, Van Craenenbroeck J, Jumapili N, Barthelmess R, et al.
Proc Natl Acad Sci U S A
. 2024 Dec;
121(52):e2409668121.
PMID: 39693339
Immunotherapies have emerged as an effective treatment option for immune-related diseases, such as cancer and inflammatory diseases. However, variations in patient responsiveness limit the broad applicability and success of these...
2.
Mostmans Y, De Smedt K, Feoli F, Waelput W, De Maertelaer V, Olemans C, et al.
Clin Exp Dermatol
. 2024 Jul;
49(12):1659-1667.
PMID: 38963799
Background: Tissue expression of endothelial cell markers of microcirculatory changes in chronic spontaneous urticaria (CSU) is poorly understood. Objectives: To explore the expression of specific endothelial cell markers [stem cell...
3.
Duhamel F, Balti E, Waelput W, Raeymaeckers S, Verfaillie G, Luyten I, et al.
Cureus
. 2024 Apr;
16(3):e56777.
PMID: 38650820
Clinical endocrinologists encounter in their practice patients with thyroid diseases on a daily basis. Still, diagnosis of rare structural thyroid disorders can be quite challenging. In some instances, they do...
4.
Gondry O, Caveliers V, Xavier C, Raes L, Vanhoeij M, Verfaillie G, et al.
J Nucl Med
. 2024 Feb;
65(2):178-184.
PMID: 38302159
Human epidermal growth factor receptor 2 (HER2) status is used for decision-making in breast carcinoma treatment. The status is obtained through immunohistochemistry or in situ hybridization. These two methods have...
5.
Nijns J, De Mesmaeker I, Suenens K, Stange G, De Groot K, Marques de Lima M, et al.
Cell Transplant
. 2023 May;
32:9636897231167323.
PMID: 37129266
Subcutaneous implants of device-encapsulated stem cell-derived pancreatic endoderm (PE) can establish a functional beta cell mass (FBM) with metabolic control in immune-compromised mice. In a study with human-induced pluripotent stem...
6.
Boudry L, Essahib W, Mateizel I, Van de Velde H, De Geyter D, Pierard D, et al.
Fertil Steril
. 2022 Mar;
117(4):771-780.
PMID: 35272846
Objective: To study the presence of viral RNA in the follicular fluid, cumulus cells, and endometrial tissue samples in SARS-CoV-2-positive women undergoing assisted reproductive technology (ART). Design: Prospective, single-center, observational...
7.
Locy H, Verhulst S, Cools W, Waelput W, Brock S, Cras L, et al.
Front Immunol
. 2022 Feb;
13:794175.
PMID: 35222378
Scoring of tumor-infiltrating lymphocytes (TILs) in breast cancer specimens has gained increasing attention, as TILs have prognostic and predictive value in HER2 and triple-negative breast cancer. We evaluated the intra-...
8.
Joris S, Fontaine C, Decoster L, Vanderauwera J, Thielemans K, Waelput W, et al.
Anticancer Res
. 2022 Feb;
42(3):1433-1437.
PMID: 35220236
Background/aim: Immunotherapy with PD-1/PDL1 blocking monoclonal antibodies has improved survival compared to the standard-of-care chemotherapy for several malignancies at different stages of these malignancies. Due to several reasons, many cancer...
9.
Christgen M, Kandt L, Antonopoulos W, Bartels S, Van Bockstal M, Bredt M, et al.
J Pathol Clin Res
. 2021 Dec;
8(2):191-205.
PMID: 34889530
Invasive lobular breast carcinoma (ILC) is the second most common breast carcinoma (BC) subtype and is mainly driven by loss of E-cadherin expression. Correct classification of BC as ILC is...
10.
Martens S, Coolens K, Van Bulck M, Arsenijevic T, Casamitjana J, Ruiz A, et al.
Gut
. 2021 Jul;
PMID: 34330784
Objective: The aggressive basal-like molecular subtype of pancreatic ductal adenocarcinoma (PDAC) harbours a ΔNp63 (p40) gene expression signature reminiscent of a basal cell type. Distinct from other epithelia with basal...